Efferocytosis Key to Wound Healing and Tissue Repair

A review highlights efferocytosis, the removal of dead cells, as crucial for efficient wound healing and tissue balance.

Efferocytosis Key to Wound Healing and Tissue Repair

Image: news-medical.net

A new review published in the journal Nature Reviews Molecular Cell Biology on May 20, 2026, highlights the critical role of efferocytosis—the process by which dead cells are cleared from the body—in promoting efficient wound repair and maintaining tissue homeostasis. The review, led by researchers at the University of California, San Francisco, synthesizes current understanding of how this process influences inflammation and tissue regeneration.

Efferocytosis is performed by specialized immune cells, such as macrophages, which recognize and engulf dying cells. The review notes that impaired efferocytosis is linked to chronic wounds, including diabetic ulcers, and inflammatory diseases. The authors emphasize that enhancing this process could lead to new therapeutic strategies for wound healing.

Key findings include the identification of specific molecular pathways, such as the phosphatidylserine recognition system, that govern efferocytosis. The review also discusses how efferocytosis triggers anti-inflammatory signals, preventing excessive tissue damage and promoting repair. The researchers call for further studies to translate these insights into clinical treatments.

❓ Frequently Asked Questions

What is efferocytosis?

Efferocytosis is the process by which dead or dying cells are cleared from the body by immune cells like macrophages, crucial for preventing inflammation and promoting tissue repair.

How does efferocytosis affect wound healing?

Efficient efferocytosis reduces inflammation and promotes tissue regeneration, while impaired efferocytosis is linked to chronic wounds and inflammatory diseases.

What are the therapeutic implications of this review?

The review suggests that enhancing efferocytosis could lead to new treatments for chronic wounds, such as diabetic ulcers, by targeting molecular pathways like phosphatidylserine recognition.

📰 Source:
news-medical.net →
Share: